Up-regulation of BTG2 activated by p53-dependent or p53-independent NF-κB signaling pathway inhibits cancer cell proliferation [49], and BTG2 also negatively regulates jAK2/STAT3 signaling to exert an anti-proliferation effects on cells [50]. The gene discussed is TP53; the disease is cancer.